NS: 25332330
Mobile: 90094424
2:00 – 6:00 pm (weekdays)
Sat. 10:30 AM - 1:30 PM.

News & Articles

25/01/2019

Investigational monoclonal antibody to treat Ebola is safe in adults

Early-stage trial results show promise. Read More

23/01/2019

Smoking linked to higher risk of peripheral artery disease in African-Americans

The condition affects 8 to 12 million people in the United States and 202 million worldwide. Read More

23/01/2019

New fellowship program will support the next generation of African scientific leaders

NIH collaborates with African Academy of Sciences and Bill & Melinda Gates Foundation. Read More

23/01/2019

Temperature-stable experimental tuberculosis vaccine enters clinical testing

Tuberculosis remains the leading infectious cause of death worldwide. Read More

23/01/2019

Blood test shows promise for early detection of severe lung-transplant rejection

New tool that uses DNA sequencing could improve transplant outcomes and save lives. Read More

23/01/2019

Dengue immunity may be protective against symptomatic Zika, study finds

Zika virus and dengue virus are both transmitted by Aedes aegypti mosquitoes and cause similar symptoms. Read More

22/01/2019

Faulty molecular master switch may contribute to AMD

NIH researchers discover that TGFβ signaling governs immune cell function in the eye. Read More

17/01/2019

New Findings Reveal Surprising Role of the Cerebellum in Reward and Social Behaviors

NIH-funded study sheds new light on brain circuits related to affective and social dysfunction. Read More

17/01/2019

NIH researchers rescue photoreceptors, prevent blindness in animal models of retinal degeneration

Findings set stage for first clinical trial of stem cell-based therapeutic approach for AMD. Read More

14/01/2019

Clinical Trial Testing Fecal Microbiota Transplant for Recurrent Diarrheal Disease Begins

Clostridium difficile, commonly referred to as C. diff, is a bacterium that infects the colon and can cause diarrhea, fever, and abdominal pain. Read More